Reviva Pharmaceuticals Holdings, Inc.
USD0.62
+0.04 (+5.98%)
CEO
Laxminarayan Bhat
IPO Date
2018-10-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.58
Prev. Close
$0.58
Day Low
$0.58
Day High
$0.62
52W Low
$0.26
52W High
$17.98
Market Cap
$0.00B
Volume
0.05M
| 109,150 |
| $1.87 |
| 20 Mar 2026 | Bhat Laxminarayan | director, officer: President and CEO | A-Award | Acquired | 40,925 | $1.87 |
| 19 Dec 2025 | Funtleyder Leslie D. | director | A-Award | Acquired | 8,200 | $0.58 |
| 19 Dec 2025 | Margolin Richard A | director | A-Award | Acquired | 8,200 | $0.58 |
| 19 Dec 2025 | Patel Purav | director | A-Award | Acquired | 8,200 | $0.58 |
| 19 Dec 2025 | SAXENA PARAG | director | A-Award | Acquired | 8,200 | $0.58 |
| 12 Dec 2024 | Funtleyder Leslie D. | director | A-Award | Acquired | 8,200 | $2.52 |
| 12 Dec 2024 | SAXENA PARAG | director, 10 percent owner: | A-Award | Acquired | 8,200 | $2.52 |
| 22 Nov 2023 | SAXENA PARAG | director, 10 percent owner: | J-Other | Acquired | 585,366 | $0.00 |